Synergy CHC Corp. Q4 2025 Earnings Call Summary

Synergy CHC Corp. Q4 2025 Earnings Call Summary - Moby

Strategic Performance and Operational Context

Management characterized 2025 as a transitional year defined by strategic groundwork in international markets and the beverage sector despite significant one-time financial impacts. The termination of a licensing agreement in the UAE and Turkey, driven by regional macro instability, necessitated a $2.5 million revenue reversal but did not change management's long-term conviction in international demand. The Beverage division is positioned as a primary 2026 growth engine, with Q1 2026 gross revenue already surpassing the entirety of 2025 following the resolution of inventory production delays. The Flat Tummy brand continues to face structural declines as the weight loss category shifts heavily toward GLP-1 medications, prompting a pending strategic review of the asset. Management attributed the lack of same-store growth in the supplement business to the absence of TV advertising, which they identified as a critical competitive necessity for retail performance. Operational expansion in Mexico via a new wholly owned subsidiary has successfully initiated shipments to Costco Mexico, serving as a template for direct retail network building.

2026 Strategic Outlook and Growth Drivers

Reinstating TV advertising is the top operational priority for 2026, with management modeling at least a 15% lift in same-store sales based on historical performance trends. The Beverage division is projected to reach a $2.5 million revenue run rate in 2026, supported by millions of units in stock and new distribution through major convenience and wholesale partners. International growth will focus on executing existing initiatives in Mexico and pursuing capital-efficient, scalable expansion in other markets through licensing. Management expects normalized gross margins to remain stable or increase as the business moves past one-time items such as inventory write-offs, while operating expenses are expected to normalize following the 2025 bad debt allowances. Upcoming retail catalysts include scheduled roadshows at Costco and BJ's Wholesale Club to drive volume for the functional beverage portfolio.

Non-Recurring Items and Risk Factors

Financial results were heavily skewed by $11.5 million in one-time charges, including a $6.66 million bad debt allowance and a $2.9 million license revenue reversal. A $1.04 million write-off for obsolete inventory and a $0.9 million write-off of prepaid media credits further impacted the Q4 operating loss. Professional fees related to corporate development activities significantly increased operating expenses beyond historical normalized levels. The company achieved a working capital surplus of $1.78 million at year-end, a notable improvement from the $1.12 million deficit in the prior year.

Story Continues

Q&A Session Highlights

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Beverage division revenue timing and inventory availability

Management explained that low 2025 beverage revenue was due to the 8-12 week lead time required to build inventory after securing funding in August. The majority of RTD (Ready-to-Drink) inventory only arrived in December, shifting the primary sales impact to early 2026.

Strategic outlook for Flat Tummy and weight loss category

Management acknowledged the brand is struggling as the industry moves toward GLP-1 drugs. A strategic decision regarding the future of the Flat Tummy business line is expected in the near future.

International expansion strategy and Mexico subsidiary

The company confirmed it has no immediate plans to open additional international subsidiaries beyond Mexico. The focus remains on executing within the newly established Mexican retail network rather than spreading resources across new direct markets.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.

View Comments